Carbapenem-Resistant Infections in India: Causes, Symptoms, Treatment & Prevention
Why does an infection sometimes fail to improve even after treatment with a powerful antibiotic? One possible reason is antibiotic resistance. Among the most difficult cases are carbapenem resistant infections, where bacteria can withstand important antibiotics such as meropenem or imipenem. For a patient or family member, a laboratory report mentioning “carbapenem resistance” can sound alarming. But resistance does not automatically mean that an infection is untreatable. It means your doctor may need more information before choosing an effective medicine.
India has been monitoring this problem for years. ICMR identifies carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii as important healthcare-associated threats.
What Are Carbapenem-Resistant Infections?
Carbapenems are antibiotics used for many serious bacterial infections. When bacteria develop mechanisms that allow them to survive these medicines, treatment becomes more complicated. The term carbapenem resistant infections covers several different organisms rather than one particular disease.
The major groups include:
- CRE: Carbapenem-resistant Enterobacterales
- CRAB: Carbapenem-resistant Acinetobacter baumannii
- CRPA: Carbapenem-resistant Pseudomonas aeruginosa
These bacteria can cause infections involving the lungs, urinary tract, bloodstream, abdomen, wounds, and other sites. ICMR has specifically highlighted the importance of carbapenem-resistant Gram-negative organisms in Indian hospitals.
Which Bacteria Can Become Carbapenem Resistant?
Several carbapenem resistant bacteria can cause serious disease.
Common examples include:
- Klebsiella pneumoniae
- Escherichia coli
- Acinetobacter baumannii
- Pseudomonas aeruginosa
- Other Enterobacterales
One important point is often missed: not every resistant bacterium behaves in the same way.
For example, some bacteria produce enzymes called carbapenemases. Others may combine different resistance mechanisms, including changes that reduce antibiotic entry into the bacterial cell. The exact mechanism can influence which treatments remain useful. The 2026 IDSA guidance recommends considering the specific carbapenemase family when making treatment decisions for CRE.
What Causes Carbapenem Resistance in India?
There isn’t one simple answer.
Unnecessary antibiotic use
Antibiotics do not treat viral illnesses such as most common colds. Using them when they are not needed creates additional pressure on bacteria.
Previous antibiotic exposure
Someone who has recently received antibiotics may be more likely to carry resistant organisms. This is particularly relevant when several antibiotic courses have been used.
Long hospital stays
Intensive-care treatment, invasive procedures and prolonged hospitalisation can increase exposure to resistant bacteria.
Weak infection-control practices
Resistant organisms can spread through hands, equipment and contaminated surfaces. Good hand hygiene, sterilisation and infection-control procedures therefore matter.
Multiple resistance mechanisms
A bacterium may acquire more than one mechanism at the same time. That can turn an ordinary bacterial infection into a multidrug resistant infection with fewer effective treatment choices.
What Symptoms Should You Watch For?
There is no single symptom that tells you an infection is carbapenem resistant. The symptoms usually depend on the infection site. Lung infection: cough, fever, breathing difficulty or chest discomfort. Urinary infection: burning urination, frequent urination, lower abdominal discomfort, or fever. Bloodstream infection: fever, chills, weakness, confusion, or low blood pressure. Wound infection: increasing pain, redness, swelling, or discharge.
Abdominal infection: abdominal pain, fever, vomiting, or tenderness. These symptoms can also occur with ordinary bacterial infections. Resistance is generally identified through laboratory testing rather than symptoms alone.
How Are Carbapenem-Resistant Infections Diagnosed?
This is where proper testing becomes extremely important. A healthcare professional may collect an appropriate clinical sample and send it for culture and antimicrobial susceptibility testing (AST).
The laboratory can identify the organism and determine which antibiotics are active against it.
In some situations, additional tests can identify carbapenemase enzymes or other resistance mechanisms.
Think of the process this way:
Sample → organism identification → susceptibility testing → resistance mechanism, when appropriate → treatment decision
That information is much more useful than simply asking for a “stronger antibiotic.”
There is also an important distinction between colonisation and infection. A person can carry a resistant organism without it actually causing disease. The 2026 IDSA guidance specifically stresses the importance of distinguishing colonisation from infection to avoid unnecessary antibiotic exposure.
What Is the Treatment for Carbapenem-Resistant Infections?
Treatment depends on several factors:
- The bacteria causing the infection
- The location and severity of infection
- Susceptibility test results
- The resistance mechanism
- Kidney and liver function
- Previous antibiotic exposure
- The patient’s overall condition
So, there is no single carbapenem resistant infection treatment that works for everyone.
The 2026 IDSA guidance recommends basing treatment choices on the identified organism and demonstrated susceptibility, with resistance mechanisms helping guide decisions for CRE.
For selected resistant Gram-negative infections, clinicians may consider newer or specialised antimicrobial options when laboratory results support their use. Aarokiyam’s portfolio includes ZIDABACTUM (ceftazidime + avibactam), which can be discussed when explaining β-lactam/β-lactamase inhibitor options.
Other medicines may have roles in specific clinical circumstances. Polytryp Plus (polymyxin B) and AVITIGA (tigecycline) can be discussed as examples of antimicrobial options that may be considered for selected difficult-to-treat infections.
Aarokiyam’s AVIMERO-S (meropenem + sulbactam) also provides an opportunity to explain an important point: a medicine should never be selected simply because an infection is labelled “resistant.” The organism’s actual susceptibility and resistance mechanism must guide treatment.
These medicines should be used only under appropriate medical supervision.
Why Isn’t the “Strongest Antibiotic” Always the Best?
This is one of the biggest misunderstandings about antibiotic treatment.You might assume that a more powerful antibiotic is automatically better. In reality, doctors want the most appropriate active treatment, not simply the broadest one.
For example, continuing unnecessary combination therapy can increase adverse effects without necessarily improving outcomes. The 2026 IDSA guidance does not routinely recommend combination therapy for CRE once an active β-lactam has been identified.
The goal is simple:
Identify the bacteria → understand resistance → choose an active medicine → control the source of infection → monitor the response.
How Can You Prevent These Infections?
You can make a difference through simple habits.
For patients
- Never take antibiotics without medical advice.
- Don’t use leftover antibiotics.
- Don’t share medicines with family members.
- Follow the prescribed treatment instructions.
- Tell your doctor about recent antibiotic use.
- Mention previous hospitalisation when relevant.
- Follow hand-hygiene advice.
- Ask whether diagnostic testing is appropriate.
For hospitals
Effective prevention also requires antimicrobial stewardship, reliable microbiology services, infection-control programmes and regular monitoring of local resistance patterns.
These measures help reduce unnecessary antibiotic exposure and identify outbreaks earlier.
What Should You Ask Your Doctor?
If you or your family member has been told that a bacterium is carbapenem resistant, don’t panic—and don’t start searching for the strongest antibiotic yourself.
Ask:
- Which bacteria was identified?
- Is this colonisation or an actual infection?
- What does the susceptibility report show?
- Has the resistance mechanism been identified?
- Which treatment is appropriate for this particular infection?
These questions can help you understand what is happening and why a particular treatment has been chosen.
The Bottom Line
Carbapenem resistant infections are a serious challenge, but resistance does not mean that every treatment option has disappeared.
The better approach is to identify the organism, understand its resistance mechanism, check susceptibility, and then select treatment according to the patient’s needs.
For you, the most useful rule is simple: don’t look for the strongest antibiotic. Look for the right diagnosis and the right treatment.
For healthcare professionals and organisations working in anti-infectives, including Aarokiyam, responsible antimicrobial use is just as important as access to appropriate medicines. The fight against resistance depends on both.
FAQs
They can be serious, particularly in critically ill or hospitalised patients, because treatment choices may be limited. However, the outcome depends on the organism, infection site, resistance pattern and patient’s condition.
Yes. Some infections can be treated with medicines that remain active against the particular organism. Laboratory susceptibility testing is an important part of selecting treatment.
Carbapenem resistance is a specific type of antibiotic resistance. It refers to bacteria that can withstand one or more carbapenem antibiotics.
Yes. Colonisation can occur without an active infection. This is why a positive laboratory result needs to be interpreted alongside the patient’s symptoms and clinical condition.
Use antibiotics only when medically appropriate, follow infection-prevention practices, maintain good hand hygiene and avoid self-medication.
Contact Us
Want to discuss bulk orders?
Fill out the enquiry form below, and our team will respond promptly with all the details you need. At Aarokiyam Lifesciences, we’re committed to delivering quality products and exceptional service to meet your healthcare needs.